(0.13%) 5 315.05 points
(0.12%) 39 854 points
(0.07%) 16 806 points
(-0.61%) $79.31
(-3.16%) $2.66
(-0.62%) $2 423.30
(-0.90%) $32.14
(-0.20%) $1 061.60
(0.05%) $0.921
(-0.28%) $10.67
(-0.03%) $0.787
(-0.40%) $90.31
2.19% $ 1.635
Live Chart Being Loaded With Signals
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 794 901 |
Średni wolumen | 1.94M |
Kapitalizacja rynkowa | 205.61M |
EPS | $0 ( 2024-05-20 ) |
Następna data zysków | ( $-0.0500 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.81 |
ATR14 | $0.00400 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Finn Jonathan | Buy | 25 000 | Common Stock |
2024-03-09 | Cigler Tessa | Buy | 20 834 | Stock Option (right to buy) |
2024-03-09 | Cigler Tessa | Buy | 0 | |
2023-11-15 | Weaver Gregory L | Sell | 50 000 | Common Stock |
2023-11-15 | Finn Jonathan | Buy | 62 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
70.91 |
Last 98 transactions |
Buy: 26 594 652 | Sell: 4 017 362 |
Wolumen Korelacja
Atossa Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
GIFI | 0.952 |
LFMDP | 0.948 |
SG | 0.946 |
RPAY | 0.937 |
RGLS | 0.929 |
SWBI | 0.929 |
CPRT | 0.926 |
PUBM | 0.926 |
MNMD | 0.925 |
DXPE | 0.924 |
10 Najbardziej negatywne korelacje | |
---|---|
RETO | -0.916 |
RGF | -0.911 |
UONEK | -0.909 |
EEIQ | -0.909 |
HRZN | -0.909 |
TCPC | -0.905 |
CLEU | -0.901 |
TTEC | -0.898 |
QNRX | -0.897 |
GAN | -0.897 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Atossa Therapeutics Inc Korelacja - Waluta/Towar
Atossa Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-8 000.00 (0.00 %) |
EPS: | $-0.210 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.180 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Atossa Therapeutics Inc
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej